Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.

Article  Google Scholar 

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89. https://doi.org/10.1002/ijc.33588.

Article  CAS  Google Scholar 

View of Global Cancer Statistics: The trends projection analysis. (n.d.). 2022 https://pubs.thesciencein.org/journal/index.php/cbl/article/view/451/293

Gridelli C, Rossi A, Carbone DP, Guarize J, Karachaliou N, Mok T, Petrella F, Spaggiari L, Rosell R. Non-small-cell lung cancer. Natre Rev Dis Prim. 2015. https://doi.org/10.1038/nrdp.2015.9.

Article  Google Scholar 

Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–40. https://doi.org/10.1016/j.mayocp.2019.01.013.

Article  CAS  PubMed  Google Scholar 

Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol, Biomark Prev. 2019;28(10):1563–79. https://doi.org/10.1158/1055-9965.epi-19-0221.

Article  Google Scholar 

Colby TV, Wistuba II, Gazdar A. Precursors to pulmonary neoplasia. Adv Anatomic Pathol. 1998;5(4):205–15. https://doi.org/10.1097/00125480-199807000-00001.

Article  CAS  Google Scholar 

Yano T, Haro A, Shikada Y, Maruyama R, Maehara Y. Non-small cell lung cancer in never smokers as a representative ‘non-smoking-associated lung cancer’: epidemiology and clinical features. Int J Clin Oncol. 2011;16(4):287–93. https://doi.org/10.1007/s10147-010-0160-8.

Article  CAS  PubMed  Google Scholar 

Balan S, Saxena M, Bhardwaj N. Dendritic cell subsets and locations. Int Rev Cell Mol Biol. 2019. https://doi.org/10.1016/bs.ircmb.2019.07.004.

Article  PubMed  Google Scholar 

Cassetta L, Kitamura T. Macrophage targeting: opening new possibilities for cancer immunotherapy. Immunology. 2018;155(3):285–93. https://doi.org/10.1111/imm.12976.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szabo SJ, Sullivan BM, Peng SL, Glimcher LH. Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol. 2003;21(1):713–58. https://doi.org/10.1146/annurev.immunol.21.120601.140942.

Article  CAS  PubMed  Google Scholar 

Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature. 1996;383(6603):787–93. https://doi.org/10.1038/383787a0.

Article  CAS  PubMed  Google Scholar 

Biswal S, Mehta R. Cutaneous adverse reactions of chemotherapy in cancer patients: a clinicoepidemiological study. Ind J Dermatol. 2018;63(1):41. https://doi.org/10.4103/ijd.ijd_65_17.

Article  Google Scholar 

Sun LX, Li WD, Lin ZB, Duan XS, Li XF, Yang N, Lan TF, Li M, Sun Y, Yu M, Lu J. Protection Against Lung Cancer Patient Plasma-Induced Lymphocyte Suppression by Ganoderma LucidumPolysaccharides. Cell Physiol Biochem. 2014;33(2):289–99. https://doi.org/10.1159/000356669.

Article  CAS  PubMed  Google Scholar 

Peschel W, Kump A, Prieto JM. Effects of 20-hydroxyecdysone, Leuzea carthamoides extracts, dexamethasone and their combinations on the NF-κB activation in HeLa cells. J Pharm Pharmacol. 2011;63(11):1483–95. https://doi.org/10.1111/j.2042-7158.2011.01349.x.

Article  CAS  PubMed  Google Scholar 

Kaushik RR, Koranne M, Rao MS, Rakshit S, Shanmugam G, George M, Sarkar K. Role of Diospyros peregrina fruit preparation in suppressing regulatory T (Treg) cells in the tumor microenvironment of breast and lung cancer. Phytomedicine Plus. 2022;2(4):100353. https://doi.org/10.1016/j.phyplu.2022.100353.

Article  Google Scholar 

Y, A, G, B, SA. (2012). Antitumor and antioxidant activity of Diospyros peregrina against Dalton’s ascites lymphoma in rodents. Annal Biol Res. 2012; 3 11:4985–4992. https://www.scholarsresearchlibrary.com/articles/antitumor-and-antioxidant-activity-of-diospyros-peregrina-against-daltonsascites-lymphoma-in-rodents.pdf. Accessed 22 from 2023

Raju AB, Venu Gopal Y, Ravindranath A, Kalpana G, Prabhakar RV. Antitumor activity of Diospyros peregrina on ehrlich ascites carcinoma in mice. J Sci Res. 2011;3(2):413–9. https://doi.org/10.3329/jsr.v3i2.6787.

Article  CAS  Google Scholar 

Roy A, Ghosh A, Sinha K, Mitra B, Rakshit S, George M, Sarkar K. Diospyros peregrina fruit preparation mediated immunomodulation of lymphocytes isolated from the blood of breast cancer patients. Iran J Immunol. 2021;18(2):111–8. https://doi.org/10.22034/iji.2021.85430.1710.

Article  PubMed  Google Scholar 

Mahalakshmi Surendran A, Rai A, Rakshit S, George M, Sarkar K. Immunomodulatory role of Diospyros peregrina fruit preparation in breast cancer by utilizing macrophage mediated antigen presentation and T helper cell (Th) differentiation. Clin Breast Cancer. 2023;23(3):e95–102. https://doi.org/10.1016/j.clbc.2022.12.020.

Article  CAS  PubMed  Google Scholar 

Bøyum A. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens. 1974;4(3):269–74. https://doi.org/10.1111/j.1399-0039.1974.tb00252.x.

Article  PubMed  Google Scholar 

Petersen TR, Dickgreber N, Hermans IF. Tumor antigen presentation by dendritic cells. Crit Rev™ in Immunol. 2010;30(4):345–86. https://doi.org/10.1615/critrevimmunol.v30.i4.30.

Article  CAS  Google Scholar 

Sarkar K, Bose A, Chakraborty K, Haque E, Ghosh D, Goswami S, Chakraborty T, Laskar S, Baral R. Neem leaf glycoprotein helps to generate carcinoembryonic antigen specific anti-tumor immune responses utilizing macrophage-mediated antigen presentation. Vaccine. 2008;26(34):4352–62. https://doi.org/10.1016/j.vaccine.2008.06.048.

Article  CAS  PubMed  Google Scholar 

Mukherjee O, Paul S, Das S, Rakshit S, Shanmugam G, George M, Sarkar K. Doxorubicin induced epigenetic regulation of dendritic cell maturation in association with T cell activation facilitates tumor protective immune response in non-small cell lung cancer (NSCLC). Pathol—Res Pract. 2024;253:155004. https://doi.org/10.1016/j.prp.2023.155004.

Article  CAS  PubMed  Google Scholar 

Li Y, Zhao C, Liu J, Lu Z, Lu M, Gu J, Liu R. CD1d highly expressed on DCs reduces lung tumor burden by enhancing antitumor immunity. Oncol Rep. 2019. https://doi.org/10.3892/or.2019.7037.

Article  PubMed  PubMed Central  Google Scholar 

Fried S, Tosun S, Troost G, Keil S, Zaenker KS, Dittmar T. Lipopolysaccharide (LPS) promotes apoptosis in human breast epithelial × breast cancer hybrids, but not in parental cells. PLoS ONE. 2016;11(2):e0148438. https://doi.org/10.1371/journal.pone.0148438.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janeway AJC, Travers P, Walport M, Shlomchik, MJ. (2001, January 1). T cell-mediated cytotoxicity—Immunobiology—NCBI Bookshelf. T Cell-mediated Cytotoxicity—Immunobiology - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK27101/

Sabado RL, Balan S, Bhardwaj N. Dendritic cell-based immunotherapy. Cell Res. 2016;27(1):74–95. https://doi.org/10.1038/cr.2016.157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Faget J, Biota C, Bachelot T, Gobert M, Treilleux I, Goutagny N, Durand I, Léon-Goddard S, Blay JY, Caux C, Ménétrier-Caux C. Early detection of tumor cells by innate immune cells leads to treg recruitment through CCL22 production by tumor cells. Cancer Res. 2011;71(19):6143–52. https://doi.org/10.1158/0008-5472.can-11-0573.

Article  CAS  PubMed  Google Scholar 

Tokumaru Y, Le L, Oshi M, Katsuta E, Matsuhashi N, Futamura M, Yoshida K, Takabe K. Association of Th2 high tumors with aggressive features of breast cancer. J Clin Oncol. 2020;38:e12584–e12584.

Article  Google Scholar 

Frafjord A, Buer L, Hammarström C, Aamodt H, Woldbæk PR, Brustugun OT, Helland S, Øynebråten I, Corthay A. The immune landscape of human primary lung tumors is Th2 skewed. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.764596.

Article  PubMed  PubMed Central  Google Scholar 

Chang SH, Mirabolfathinejad SG, Katta H, Cumpian AM, Gong L, Caetano MS, Moghaddam SJ, Dong C. T helper 17 cells play a critical pathogenic role in lung cancer. Proc Natl Acad Sci. 2014;111(15):5664–9. https://doi.org/10.1073/pnas.1319051111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Indigenous Drugs of India. The indian medical gazette. 1892. 27 9:271–273. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136941/

Mallavadhani U, Panda AK, Rao Y. Review article number 134 pharmacology and chemotaxonomy of diospyros. Phytochemistry. 1998;49(4):901–51. https://doi.org/10.1016/s0031-9422(97)01020-0.

Article  CAS  PubMed  Google Scholar 

Dewanjee S, Kundu M, Maiti A, Majumdar R, Majumdar A, Mandel SC. In vitro evaluation of antimicrobial activity of crude extract from plants Diospyros peregrine, Coccinia grandis and Swietenia macrophylla. Trop J Pharm Res. 2007. https://doi.org/10.4314/tjpr.v6i3.14658.

Article  Google Scholar 

Dewanjee S, Das AK, Sahu R, Gangopadhyay M. Antidiabetic activity of Diospyros peregrina fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem Toxicol. 2009;47(10):2679–85. https://doi.org/10.1016/j.fct.2009.07.038.

Article  CAS  PubMed  Google Scholar 

Alex AT, Nawagamuwa NH, Joseph A, Rao JV, Mathew JA, Udupa N. In vitro anti-cancer and anti-oxidant activity of different fractions of Diospyros peregrina unripe fruit extract. Free Radic Antioxid. 2012;2(4):45–9. https://doi.org/10.5530/ax.2012.4.8.

Article  CAS